Women of childbearing age must undergo a negative pregnancy test (βHCG) before starting treatment. Women and men of childbearing age (sexual relationships with women of childbearing age) must agree to use them effectively during treatment and 6 months after the last dose of treatment Contraceptive measures;
Signature of patient information and informed consent.
You may not be if
Women who are pregnant or nursing, or have fertility but refuse to take contraceptive measures;
During the enrollment period, a serious active infection requiring antibiotic intravenous treatment occurred;
Those who are allergic to test drugs;
Presence of ≥2 grade neuropathy (CTCAE 5.0);
Uncontrolled, symptomatic brain metastases or those with a history of difficult-to-control mental illness or severe intellectual or cognitive dysfunction;
Suffering from active, known or suspected autoimmune diseases (including but not limited to: uveitis, enteritis, hepatitis, pituitary inflammation, nephritis, vasculitis, hyperthyroidism, hypothyroidism and the need for bronchodilators Treatment of asthma, etc.). Subjects with hypothyroidism who only need hormone replacement therapy and skin diseases that do not require systemic treatment (such as vitiligo, psoriasis, or hair loss) can be selected;
Have been vaccinated or will be vaccinated with live vaccine within 30 days before the administration of Camrelizumab;
Congestive heart failure, uncontrolled arrhythmia, myocardial infarction, unstable angina, stroke or transient ischemic attack within 6 months; or other patients who cannot tolerate surgery;
Suffering from other malignant tumors within 5 years, except for fully treated cervical carcinoma in situ or squamous cell carcinoma of the skin, or basal cell carcinoma of the skin that has been basically controlled;
Patients who cannot comply with the trial protocol or cannot cooperate with follow-up;
The patient has already participated in another clinical trial;
People deprived of their liberty or guardianship;
Unable to receive medical supervision during the trial due to geographical, social or psychological reasons;
Patients who cannot follow the trial protocol or cannot cooperate with follow-up;
The researchers believe that it is not appropriate to participate in this experiment.
